SignalChem Biotech Inc. (@SignalChem) header
SignalChem Biotech Inc. (@SignalChem) profile picture

Pioneering Enzyme and Cell Signaling Protein Solutions for Drug Discovery & Development | Now Part of @Sino_Biological

Vancouver, Canada
Joined October 2010
Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)Photo by SignalChem Biotech Inc. (@SignalChem)
SignalChem Biotech Inc. retweeted
Come by @ImperialMed @ImperialImmuno @ImperialSci @ImperialInfect @CBRB_Imperial #flowersbuilding Want to win a @GIANTmicrobes today? Also grab a free totebag and talk to @ChandniStratech about our 4mil products and how we can help with all your #research requirements
3
6
229
SignalChem Biotech Inc. retweeted
JUST IN (and finally...): Pembrolizumab hits OVERALL SURVIVAL in KYN-564 adjuvant study in Kidney Cancer!!! The time has finally come... via @BusinessWire @DanaFarber_GU @tompowles1 @OncoAlert @OncBrothers @OncLive @TargetedOnc @urotoday @Uromigos @ALLIANCE_org @eaonc @SWOG businesswire.com/news/home/2…
13
169
27
481
86,627
SignalChem Biotech Inc. retweeted
Exciting News! We're expanding our global presence and enhancing our product portfolio. We're thrilled to announce that we have entered a Share Purchase Agreement to acquire @SignalChem Biotech Inc., a Vancouver-based Canadian #biotech company. Learn more: sinobiological.com/news/acqu…
1
1
372
SignalChem Biotech Inc. retweeted
Prostate cancer research is supported by current genomic technologies - Uncovering common mutations, gene amplifications, somatic copy number variants and chromosomal rearrangements nature.com/articles/modpatho…
1
1
SignalChem Biotech Inc. retweeted
When cancer patients should ask for genetic sequencing ti.me/2pUoS0t
1
51
5
69
SignalChem Biotech Inc. retweeted
Translation from circular RNA (#CircRNA) is regulated by m6A #methylation nature.com/cr/journal/v27/n6…
SignalChem Biotech Inc. retweeted
Researchers create a #DNA #methylation map of cancer at single base-pair resolution #epigenetics biotech-spain.com/en/article…
#Alzheimer's Affects Twice As Many People As Estimated, And The Numbers Are Climbing via @forbes forbes.com/sites/daviddisalv…
SignalChem Biotech Inc. retweeted
#PMSA is a molecular toggle switch that attenuates #MAPK signaling and turns on the PI3K/AKT pathway in... fb.me/1fRXqFjgJ
2
1
SignalChem Biotech Inc. retweeted
87 experimental therapies for #glioblastoma are in the works #BTSM statnews.com/2017/07/21/mcca… via @statnews
1
2
SignalChem Biotech Inc. retweeted
#Histone H1 prevents #genomic instability by suppressing DNA:RNA hybrids (R-loops) in heterochromatin nature.com/articles/s41467-0…
SignalChem Biotech Inc. retweeted
Cancer is ‘natural.’ The best treatments for it aren’t statnews.com/2017/08/29/canc… via @statnews
SignalChem Biotech Inc. retweeted
AKT/FOXM1/STMN1 drives #TKI resistance in lung #cancer #lcsm @BrJCancer nature.com/bjc/journal/v117/…
SignalChem Biotech Inc. retweeted
Naturally derived chemical from black poplar (6E11) inhibits the necroptosis factor RIPK1... fb.me/zl0VreOj
SignalChem Biotech Inc. retweeted
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation - klou.tt/ewl88c1gy9t0
SignalChem Biotech Inc. retweeted
Dacomitinib treatment offers longer progression-free survival over gefitinib #lcsm teapawt.net/PulmAdvisor/status/922…
#Researchers compared first generation #EGFR-tyrosine #kinase inhibitors to second generation agents ow.ly/DiRy30g168Q @TheLancetOncol
SignalChem Biotech Inc. retweeted
Preventing HDAC6 activation by blocking Ubiquitin binding - implications towards multiple myeloma and lymphoma #mmsm pubs.acs.org/doi/abs/10.1021…
SignalChem Biotech Inc. retweeted
Cigarette smoke induces DNA hypermethylation patterns similar to those in cancers nature.com/articles/nrc.2017…